Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Zolpidem Hemitartarate 1.75 mg in Healthy Volunteers
NCT02814058Phase 1Completed
- Sponsor
- Biolab Farmacêutica
- Start
- Jul 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zolpidem in Insomnia (2 arms), sponsored by Biolab Farmacêutica. Primary endpoints: Area under the curve (0-last) at 24 hours, Area under the curve (0-inf) at 24 hours and 6 more. Started Jul 2017; status: completed.
02
Drugs
zolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02814058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814058.